Our aim is to help our region become the favoured location for inward life science investment, life science business creation and growth

AHSN Innovation Exchanges

All 15 AHSNs support the regional ‘import and export’ of healthcare innovation through our Innovation Exchange. The Oxford AHSN Innovation Exchange will go live in Spring 2019.

The Innovation Exchange is an AHSN coordinated approach to identify, select and support the adoption of innovations that improve our economy and patients’ lives.

The Innovation Exchange identifies innovations for the Accelerated Access Collaborative and for local adoption. The Accelerated Access Collaborative is a national partnership of organisations including NHS England, Department of Health and Social Care, Department for Business Energy and Industrial Strategy, NICE, NHS Improvement and the AHSNs.

The Innovation Exchange has four structured elements:

  • Needs definition – we support our Sustainability and Transformation Partnerships (STPs) and Integrated Care Systems (ICSs) to identify proven solutions to existing challenges.
  • Innovator support and signposting – innovator support is provided by all AHSNs. The Innovation Pathway sets out the range of service offered. There is a consistent and coordinated offer to innovators wherever they are identified in the system.
  • Real world validation – real world validation is informed by regional and local need and seeks to provide the information and evidence needed to enable adoption of the innovation in a variety of settings.
  • Spread and adoption of supported innovations – the Innovation Exchange supports the adoption of innovations identified by the Accelerated Access Collaborative. It also identifies and supports the adoption of innovations on a regional and cross-regional basis.

Funded by the government’s Office for Life Sciences, the Innovative Exchange builds on AHSNs’ unique expertise and cross-sector connections, enabling us to identify common challenges and quickly bring people and organisations together to develop, test and spread proven innovation.

Further information can be found here

 

Contact: Julie Hart

Julie Hart
Director of Strategic and Industry Partnerships

Julie initially trained as a research microbiologist for Unilever. Since then Julie has been leading commercial teams in the diagnostics and life sciences businesses for nearly 25 years prior to joining the National Institute of Health Research (NIHR) Diagnostic Evidence Co-operative (DEC) London at Imperial College in 2013. Julie joined the Oxford AHSN in 2014 as Associate Director of Networking then went on to set up the Diagnostics and Precision Medicine programme before being appointed Director of Strategic and Industry Partnerships in 2019.
Email Julie

 

Back to Top
Responsive Menu Pro Image Responsive Menu Clicked Image
Menu